Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion type Assertion NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_head.
- NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion wasGeneratedBy ECO_0000203 NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_provenance.
- NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion wasDerivedFrom befree-20150227 NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_provenance.
- NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion SIO_000772 12686563 NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_provenance.
- NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion evidence source_evidence_literature NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_provenance.
- NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_assertion description "[Re-expression of HSulf-1 in ovarian cancer cell lines resulted in diminished HSPG sulfation, diminished phosphorylation of receptor tyrosine kinases that require sulfated HSPGs as co-receptors for their cognate ligands, and diminished downstream signaling through the extracellular signal-regulated kinase pathway after treatment with fibroblast growth factor-2 or heparin-binding epidermal growth factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869972.RAAcJoFv9VU9bx5QelI6zOAusQvW-g11pbdO8N9QY8iKI130_provenance.